EXOME ASSET MANAGEMENT LLC
Latest 13F filing data - Q1 2026
Holdings (Top positions)
| Stock | Ticker | ||
|---|---|---|---|
 | ADAG | 737K | $2.89M |
 | VSTM | 637K | $3.37M |
 | PALI | 600K | $1.05M |
 | CTMX | 521K | $2.45M |
 | ALMS | 279K | $6.15M |
 | COGT | 279K | $10.72M |
 | RLAY | 278K | $2.77M |
 | ELVN | 220K | $8.63M |
 | MLTX | 215K | $4.01M |
 | GLUE | 179K | $2.95M |
 | AVTX | 159K | $2.38M |
 | TXG | 154K | $3.27M |
 | CBIO | 153K | $2.81M |
 | FDMT | 131K | $1.22M |
 | AGIO | 125K | $4.23M |
 | NXTC | 116K | $1.22M |
 | VERA | 115K | $4.63M |
 | IONS | 110K | $8.26M |
 | CYTK | 104K | $6.84M |
 | MAZE | 89K | $2.64M |
Adagene Inc.
ADAG
Shares Held
737K
Value
$2.89M
Verastem, Inc.
VSTM
Shares Held
637K
Value
$3.37M
Palisade Bio, Inc.
PALI
Shares Held
600K
Value
$1.05M
CytomX Therapeutics, Inc.
CTMX
Shares Held
521K
Value
$2.45M
Alumis Inc.
ALMS
Shares Held
279K
Value
$6.15M
Cogent Biosciences, Inc.
COGT
Shares Held
279K
Value
$10.72M
Relay Therapeutics, Inc.
RLAY
Shares Held
278K
Value
$2.77M
Enliven Therapeutics, Inc.
ELVN
Shares Held
220K
Value
$8.63M
MoonLake Immunotherapeutics
MLTX
Shares Held
215K
Value
$4.01M
Monte Rosa Therapeutics, Inc.
GLUE
Shares Held
179K
Value
$2.95M
Avalo Therapeutics, Inc.
AVTX
Shares Held
159K
Value
$2.38M
10x Genomics, Inc.
TXG
Shares Held
154K
Value
$3.27M
Crescent Biopharma, Inc.
CBIO
Shares Held
153K
Value
$2.81M
4D Molecular Therapeutics, Inc.
FDMT
Shares Held
131K
Value
$1.22M
Agios Pharmaceuticals, Inc.
AGIO
Shares Held
125K
Value
$4.23M
NextCure, Inc.
NXTC
Shares Held
116K
Value
$1.22M
Vera Therapeutics, Inc.
VERA
Shares Held
115K
Value
$4.63M
Ionis Pharmaceuticals, Inc.
IONS
Shares Held
110K
Value
$8.26M
Cytokinetics, Incorporated
CYTK
Shares Held
104K
Value
$6.84M
Maze Therapeutics, Inc.
MAZE
Shares Held
89K
Value
$2.64M